Full List of LIDR Publications

2016

Schoenlaub et al. 2016. Coxiella burnetii avirulent nine mile phase II induces caspase -1- dependent pyroptosis in murine peritoneal B1a B cells. Infect Immun.

Keleher and Skyberg 2016. Activation of bovine neutrophils by Brucella spp. Vet Immunol Immunopathol.

Zhang 2016. Lipopolysaccharide-targeted peptide mimic vaccine against Q fever. US Patent 9,422,545.

Lacey et al. 2016. CXCR2 mediates brucella-induced arthritis in interferon gamma-deficient mice. J Infect Dis.

Dong et al. 2016. Infection pattern and transmission potential of chikungunya virus in two New World laboratory-adapted Aedes aegypti strains. Sci Rep.

Adamovicz 2016. Select agent program impact on the IBC. In Ensuring National Biosecurity.

2015

Schoenlaub et al. 2015. Role of B cells in host defense against primary Coxiella burnetii infection. Infect Immun.

Elliott et al. 2015. Neutrophils play an important role in protective immunity against Coxiella burnetii infection. Infect Immun.

2014

Peng et al. 2014. Characterization of a lipopolysaccharide-targeted monoclonal antibody and its variable fragments as candidates for prophylaxis against the obligate intracellular bacterial pathogen Coxiella burnetii. Infect Immun.

Coate et al. 2014. Remote monitoring of the progression of primary pneumonic plague in Brown Norway rats in high-capacity, high-containment housing. Pathog Dis.

Skyberg 2014. Immunopotentiation for bacterial biodefense. Curr Top Med Chem.

2013

Elliott et al. 2013. Coxiella burnetii interaction with neutrophils and macrophages in vitro and in SCID mice following aerosol infection. Infect Immun.

Skyberg 2013. Immunotherapy for tularemia. Virulence.

Skyberg et al. 2013. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain. Infect Immun.

Franklin 2013. One medicine: collaborative research on human & animal disease for the betterment of both. Mo Med.

Zhang 2013. Formalin-inactivated Coxiella burnetii phase I vaccine-induced protection depends on B cells to produce protective IgM and IgG. Infect Immun.

Homer et al. 2013. Guidelines for biosafety training programs for workers assigned to BSL-3 research laboratories. Biosecur Bioterror.

Peters et al. 2013. Early apoptosis of macrophages modulated by injection of Yersinia pestis YopK promotes progression of primary pneumonic plague. PLoS Pathog.

2012

Eisele et al. 2012. Phagocytes and humoral immunity to pneumonic plague. Adv Exp Med Biol.

Gater et al. 2012. Host stress and immune responses during aerosol challenge of Brown Norway rats with Yersinia pestis. Front Cell Infect Microbiol.

Patel and Anderson 2012. Innate immune responses during infection with Yersinia pestis. Adv Exp Med Biol.

Patel et al. 2012. Opposing roles for interferon regulatory factor-3 (IRF-3) and type I interferon signaling during plague. PLoS Pathog.

Peters and Anderson 2012. Modulation of host cell death pathways by Yersinia species and the type III effector YopK. Adv Exp Med Biol.

2011

Eisele and Anderson 2011. Host defense and the airway epithelium: frontline responses that protect against bacterial invasion and pneumonia. J Pathog.